Maximum quantity allowed is 999
CAS RN: 141396-28-3 | Product Number: A2705
Argatroban Monohydrate
Purity: >99.0%(HPLC)
Size | Unit Price | Hyderabad | Japan* | Quantity |
---|---|---|---|---|
25MG |
₹16,000.00
|
4 | 38 |
|
*Upon orders receipt, Hyderabad stocks will be dispatched on the same day.
*Items available in Japan warehouse will be dispatched in 10-12 working days.
*INR price is exclusive of domestic taxes applicable.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
Product Number | A2705 |
Purity / Analysis Method | >99.0%(HPLC) |
Molecular Formula / Molecular Weight | C__2__3H__3__6N__6O__5S·H__2O = 526.66 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Refrigerated (0-10°C) |
Condition to Avoid | Light Sensitive,Heat Sensitive |
CAS RN | 141396-28-3 |
Related CAS RN | 74863-84-6 |
PubChem Substance ID | 253661816 |
Merck Index (14) | 779 |
MDL Number | MFCD00895735 |
Appearance | White to Almost white powder to crystal |
Purity(HPLC) | min. 99.0 area% |
Elemental analysis(Nitrogen) | 15.50 to 16.50 % |
Specific rotation [a]20/D | +160.0 to +170.0 deg(C=0.8, MeOH)(calcd.on anh.substance) |
Water | 2.5 to 4.5 % |
Melting Point | 180 °C(dec.) |
Specific Rotation | 165° (C=0.8,MeOH) |
Solubility in water | Insoluble |
Solubility (slightly sol. in) | Methanol |
Solubility (insoluble in) | Ether, Acetone |
RTECS# | TM6126625 |
References
- Comparative study on heparin and a synthetic thrombin inhibitor no. 805 (MD-805*) in experimental antithrombin III-deficient animals
- Potent inhibition of thrombin by the newly synthesized arginine derivative No. 805. The importance of stereo-structure of its hydrophobic carboxamide portion
- Selective inhibition of thrombin by (2R,4R)-4-methyl-1-[N2-[1,2,3,4-tetrahydro-8-quinolinyl)sulfonyl]-L-arginyl]-2-piperidinecarboxylic acid
- Antithrombotic actions of argatroban in rat models of venous, 'mixed' and arterial thrombosis, and its effects on the tail transection bleeding time
- Effects of a thrombin inhibitor, argatroban, on ischemic brain damage in the rat distal middle cerebral artery occlusion model.
- Argatroban (a review)
- Direct thrombin inhibitors in acute coronary syndromes: present and future (a review)
- Argatroban: Update (a review)
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.